Inventor
LU ZHONGHUI
US20 patents
⚠️ This page may combine multiple inventors who share the name “LU ZHONGHUI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
14 patentsUS6740649B2May 25, 2004
Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE)
BRISTOL MYERS SQUIBB CO31 citations92
US7294624B2Nov 13, 2007
Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
BRISTOL MYERS SQUIBB CO9 citations74
US9458171B2Oct 4, 2016
Pyrrolidinyl sulfone RORγ modulators
BRISTOL MYERS SQUIBB CO4 citations73
US7595317B2Sep 29, 2009
Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
BRISTOL MYERS SQUIBB CO7 citations73
US10865191B2Dec 15, 2020
Heterocyclic compounds useful as modulators of TNF alpha
BRISTOL MYERS SQUIBB CO1 citations62
US7888381B2Feb 15, 2011
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof
BRISTOL MYERS SQUIBB CO6 citations62
US11078186B2Aug 3, 2021
ROR γ modulators
BRISTOL MYERS SQUIBB CO0 citations61
US6936620B2Aug 30, 2005
Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
BRISTOL MYERS SQUIBB CO1 citations51
US9771320B2Sep 26, 2017
Carbocyclic sulfone RORγ modulators
BRISTOL MYERS SQUIBB CO1 citations50
US9637455B2May 2, 2017
Heterocyclic sulfone RORγ modulators
BRISTOL MYERS SQUIBB CO0 citations50
US9725443B2Aug 8, 2017
RORγ modulators
BRISTOL MYERS SQUIBB CO0 citations41
US9663469B2May 30, 2017
RORγ modulators
BRISTOL MYERS SQUIBB CO0 citations41
US10308652B2Jun 4, 2019
Tricyclic heterocyclic compounds useful as inhibitors of TNF
BRISTOL MYERS SQUIBB CO0 citations39
US9708253B2Jul 18, 2017
Cyclohexyl sulfone RORγ modulators
BRISTOL MYERS SQUIBB CO0 citations39
BRISTOL MYERS SQUIBB PHARMA CO
2 patentsWROBLESKI STEPHEN T
2 patentsUS8987268B2Mar 24, 2015
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
WROBLESKI STEPHEN T2 citations50
US8921368B2Dec 30, 2014
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
WROBLESKI STEPHEN T0 citations39